Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001691479-16-000001
Filing Date
2016-12-08
Accepted
2016-12-08 13:47:16
Documents
1
Effectiveness Date
2016-12-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12020
  Complete submission text file 0001691479-16-000001.txt   13086
Mailing Address 1616 EASTLAKE AVE E. SUITE 200 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E. SUITE 200 SEATTLE WA 98102 206-957-7300
ApoGen Biotechnologies, Inc. (Filer) CIK: 0001691479 (see all company filings)

EIN.: 471760599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-275911 | Film No.: 162041070